For the Gabapentin study, the CDSCO panel advises Sun Pharma to include diagnostic criteria for Postherpetic Neuralgia and Neuropathic Pain.

Published Date: 20 Oct 2023

New Delhi: Mentioning that specific diagnostic standards for postherpetic neuralgia (PHN) and neuropathic pain should be used in accordance with international recommendations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

FDA approves Blenrep for relapsed or refractory multiple myeloma

3.

X-ray and radar technology combined to reduce cancer screening risks

4.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

5.

Researchers discuss HER2-low and HER2-zero in breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot